Evidence of MRSE on a gentamicin and vancomycin impregnated polymethyl-methacrylate (PMMA) bone cement spacer after two-stage exchange arthroplasty due to periprosthetic joint infection of the knee

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Schmolders, Jan ^a   Hischebeth, Gunnar T R ^a   Friedrich, Max J ^a   Randau, Thomas M ^a   Wimmer, Matthias D ^a   Kohlhof, Hendrik ^a   Molitor, Ernst ^a   Gravius, Sascha ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN BONE CEMENT; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; VANCOMYCIN;

ADULT; ALGORITHM; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEBRIDEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTHERMIA; INFECTION; JOINT ASPIRATION; KNEE ARTHROPLASTY; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL COUNT; OBESITY; OSTEOARTHRITIS; OSTEOLYSIS; PERIPROSTHETIC JOINT INFECTION; POSTOPERATIVE PERIOD; REIMPLANTATION; STAPHYLOCOCCUS EPIDERMIDIS; TOBACCO DEPENDENCE; TOTAL KNEE REPLACEMENT;

ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BONE CEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENTAMICINS; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; POLYMETHYL METHACRYLATE; PROSTHESIS-RELATED INFECTIONS; REOPERATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84899113148     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-144     Document Type: Article

References (29)

1. Mortazavi SM, Vegari D, Ho A, Zmistowski B, Parvizi J. Two-stage exchange arthroplasty for infected total knee arthroplasty:predictors of failure. Clin Orthop Relat Res 2011, 469:3049-3054. 10.1007/s11999-011-2030-8, 3183212, 21866421.
2. Laffer RR, Graber P, Ochsner PE, Zimmerli W. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 2006, 12:433-439. 10.1111/j.1469-0691.2006.01378.x, 16643519.
3. Wimmer MD, Vavken P, Pagenstert GI, Valderrabano V, Randau TM, Wirtz DC, Gravius S. Spacer usage in prosthetic joint infections does not influence infect resolution: retrospective analysis of 120 joints with two-stage exchange. Re: clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of prosthetic joint infections. J Infect 2013, 67:82-84. Cabo J, Euba G, Saborido A, González-Panisello M, Domínguez MA, Agulló JL, Murillo O, Verdaguer R, Ariza J. Journal of Infection 2011 Jul, Volume: 63 Issue: 1 Pages: 23-31., 10.1016/j.jinf.2013.02.001, 23415731.
4. Trampuz A, Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly 2005, 135:243-251.
5. Azzam K, McHale K, Austin M, Purtill JJ, Parvizi J. Outcome of a second two-stage reimplantation for periprosthetic knee infection. Clin Orthop Relat Res 2009, 467:1706-1714. 10.1007/s11999-009-0739-4, 2690747, 19224302.
6. Bertazzoni Minelli E, Della Bora T, Benini A. Different microbial biofilm formation on polymethylmethacrylate (PMMA) bone cement loaded with gentamicin and vancomycin. Anaerobe 2011, 17:380-383. 10.1016/j.anaerobe.2011.03.013, 21515396.
7. Klekamp J, Dawson JM, Haas DW, DeBoer D, Christie M. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty 1999, 14:339-346. 10.1016/S0883-5403(99)90061-X, 10220189.
8. Penner MJ, Masri BA, Duncan CP. Elution characteristics of tobramycin and vancomycin combined in acrylic bone cement. J Arthroplasty 1996, 11:939-944. 10.1016/S0883-5403(96)80135-5, 8986572.
9. Bertazzonni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother 2004, 53:329-334. 10.1093/jac/dkh032, 14688051.
10. Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement. An in-vivo study using the prosthesis of antibiotic-loaded acrylic-cement (PROSTALAC). J Arthroplasty 1998, 13:331-338. 10.1016/S0883-5403(98)90179-6, 9590645.
11. Fink B, Vogt S, Reinsch M, Büchner H. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res 2011, 469:3141-3147. 10.1007/s11999-011-1937-4, 3183203, 21678099.
12. Anagnostakos K, Fürst O, Kelm J. Antibiotic-impregnated PMMA hip spacers: current status. Acta Orthop 2006, 77:628-637. 10.1080/17453670610012719, 16929441.
13. Villa T, Carnelli D. Experimental evaluation of the biomechanical performances of a PMMA-based knee spacer. Knee 2007, 14:145-153. 10.1016/j.knee.2006.11.010, 17207626.
14. Anagnostakos K, Wilmes P, Schmitt E, Kelm J. Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop 2009, 80:193-197. 10.3109/17453670902884700, 2823164, 19404802.
15. Campoccia D, Montanaro L, Speziale P, Arciola CR. Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials 2010, 31:6363-6377. 10.1016/j.biomaterials.2010.05.005, 20542556.
16. Laffer RR, Frei R, Widmer AF. Epidemiology of septicemias in a University hospital over 5 years. Schweiz Med Wochenschr 2000, 130(41):1471-8.
17. Trampuz A, Widmer AF. Infections associated with orthopedic implants. Curr Opin Infect Dis 2006, 19:349-356. 10.1097/01.qco.0000235161.85925.e8, 16804382.
18. Morawietz L, Gehrke T, Claßen RA, Barden B, Otto M, Hansen T, Aigner T, Stiehl P, Neidel JH, Schröder JH, Frommelt L, Schubert T, Meyer-Scholten C, König A, Ströbel P, Rader CP, Kirschner S, Linter F, Rüther W, Skwara A, Bos I, Kriegsmann J, Krenn V. Vorschlag für die Konsensus-Klassifikation der periprothetischen Membran gelockerter Hüft- und Knieprothesen. Pathologe 2004, 25:375-384.
19. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, Osmon DR, Mandrekar JN, Cockerill FR, Steckelberg JM, Greenleaf JF, Patel R. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007, 357:654-663. 10.1056/NEJMoa061588, 17699815.
20. Wimmer MD, Randau TM, Petersdorf S, Pagenstert GI, Weißkopf M, Wirtz DC, Gravius S. Evaluation of an interdisciplinary therapy algorithm in patients with prosthetic joint infections. Int Orthop 2013, 37:2271-2278. 10.1007/s00264-013-1995-1, 23851647.
21. Petersdorf S, Hoppe T, Hoerauf A, Pagenstert G, Wirtz D, Wimmer M, Gravius S. Increase of polymicrobial infections and multi-resistant pathogens causing prosthetic joint infections. Clin Microbiol Infect 2011, 17(Supplement s4):S109.
22. Neut D, van de Belt H, van Horn JR, van der Mei HC, Busscher HJ. Residual gentamicin-release from antibiotic-loaded polymethylmethacrylate beads after 5 years of implantation. Biomaterials 2003, 24:1829-1831. 10.1016/S0142-9612(02)00614-2, 12593965.
23. Expertenstatement Protheseninfektion in der Orthopädie. Österreichische Ärztezeitschrift 2008, Juni 2008(Supplementum):3-16.
24. Bunetel L, Segui A, Cormier M, Percheron E, Langlais F. Release of gentamicin from acrylic bone cement. Clin Pharmacokinet 1989, 17:291-297. 10.2165/00003088-198917040-00006, 2591139.
25. González Della Valle A, Bostrom M, Brause B, Harney C, Salvati EA. Effective bactericidal activity of tobramycin and vancomycin eluted from acrylic bone cement. Acta Orthop Scand 2001, 72:237-240. 10.1080/00016470152846547, 11480597.
26. Hsieh PH, Chang YH, Chen SH, Ueng SW, Shih CH. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res 2006, 24:1615-1621. 10.1002/jor.20214, 16788986.
27. Kadurugamuwa JL, Sin LV, Yu J, Francis KP, Purchio TF, Contag PR. Noninvasive optical imaging method to evaluate postantibiotic effects on biofilm infection in vivo. Antimicrob Agents Chemother 2004, 48:2283-2287. 10.1128/AAC.48.6.2283-2287.2004, 415634, 15155235.
28. Steinbrink K, Frommelt L. Treatment of periprosthetic infection of the hip using one-stage exchange surgery. Orthopade 1995, 24:335-343.
29. Clauss M, Achermann Y, Vogt M, Zimmerli W, Trampuz A. Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study. Swiss Med Wkly 2011, 141(Supplementum 186):9S.